Carregant...
Virologic response and haematologic toxicity of boceprevir- and telaprevir-containing regimens in actual clinical settings
Effectiveness, safety and tolerability of boceprevir (BOC) and telaprevir (TPV) in actual clinical settings remain unknown. We determined rates of sustained virologic response (SVR) and haematologic adverse effects among persons treated with BOC- or TPV-containing regimens, compared with pegylated i...
Guardat en:
| Publicat a: | J Viral Hepat |
|---|---|
| Autors principals: | , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2014
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5020421/ https://ncbi.nlm.nih.gov/pubmed/25524834 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jvh.12375 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|